A study of the expression and pathogenesis of Moloney murine leukemia virus (M-MuLV) is proposed. Experiments on expression center on tissue-specificity. In particular, elements within the long terminal repeat (LTR) will be investigated. We will insert or substiture sequences form heterologous viral and cellular genes into the M-MuLV by recombinant cloning techniques. The sequences will include enhancer, promoter, and promoter- proximal elements. The altered LTR's will be tested for expression in a variety of differentiated cell types. In addition, the altered LTR's will be reconstituted into replication- component M-MuLV and tested for tissue-specific infection in vitro and in vivo. These experiments may provide important information on tissue-specific transcription, and they may also be important in the design of retroviral vectors. Experiments on M-MuLV pathogenesis take advantage of the fact that several M-MuLV's with altered LTR's show altered pathogenic potential. This ranges from non-pathogenic M-MuLV's (Mo+PyF101 M-MuLV) to M-MuLV's with altered disease spectrum (PyF101+Mo M-MuLV). These viruses provide a powerful tool for investigating the nature of leukemic and preleukemic changes induced by M-MuLV. Hematopoietic tissue from preleukemic mice inoculated with wild-type M-MuLV will be characterized for preleukemic changes. Hyperplasia will be documented and characterized by flow cytometry and biological stem cell assays. The viral status of preleukemic cells will also be investigated. Mice inoculated with the variant viruses will also be examined for preleukemic charges. The variant viruses may identify both critical and irrelevant preleukemic changes. End-stage tumors induced by wild-type and variant M-MuLV's will also be studied. The cell types of the tumors will be determined, and the nature of the viruses in the tumors will be determined. The tumors will also be examined for proviral insertion in the vicinity of cellular proto-oncogenes. These studies may identify critical steps in M- MuLV induced leukemogenesis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA032455-09
Application #
3170376
Study Section
Virology Study Section (VR)
Project Start
1982-02-01
Project End
1992-01-31
Budget Start
1989-02-01
Budget End
1990-01-31
Support Year
9
Fiscal Year
1989
Total Cost
Indirect Cost
Name
University of California Irvine
Department
Type
Schools of Arts and Sciences
DUNS #
161202122
City
Irvine
State
CA
Country
United States
Zip Code
92697
Low, Audrey; Datta, Shoibal; Kuznetsov, Yurii et al. (2007) Mutation in the glycosylated gag protein of murine leukemia virus results in reduced in vivo infectivity and a novel defect in viral budding or release. J Virol 81:3685-92
Jahid, Sohail; Bundy, Linda M; Granger, Steven W et al. (2006) Chimeras between SRS and Moloney murine leukemia viruses reveal novel determinants in disease specificity and MCF recombinant formation. Virology 351:7-17
Kuznetsov, Y G; Low, A; Fan, H et al. (2005) Atomic force microscopy investigation of isolated virions of murine leukemia virus. J Virol 79:1970-4
Kuznetsov, Y G; Low, A; Fan, H et al. (2004) Atomic force microscopy investigation of wild-type Moloney murine leukemia virus particles and virus particles lacking the envelope protein. Virology 323:189-96
Datta, S; Kothari, N H; Fan, H (2001) Induction of Tax i expression in MT-4 cells by 5-azacytidine leads to protein binding in the HTLV-1 LTR in vivo. Virology 283:207-14
Granger, S W; Fan, H (2001) Purification of Moloney murine leukemia virus chromatin from infected cells by an affinity method. J Biomed Sci 8:278-89
Bonzon, C; Fan, H (2000) Moloney murine leukemia virus-induced tumors show altered levels of proapoptotic and antiapoptotic proteins. J Virol 74:8151-8
Datta, S; Kothari, N H; Fan, H (2000) In vivo genomic footprinting of the human T-cell leukemia virus type 1 (HTLV-1) long terminal repeat enhancer sequences in HTLV-1-infected human T-cell lines with different levels of Tax I activity. J Virol 74:8277-85
Granger, S W; Bundy, L M; Fan, H (1999) Tandemization of a subregion of the enhancer sequences from SRS 19-6 murine leukemia virus associated with T-lymphoid but not other leukemias. J Virol 73:7175-84
Lander, J K; Chesebro, B; Fan, H (1999) Appearance of mink cell focus-inducing recombinants during in vivo infection by moloney murine leukemia virus (M-MuLV) or the Mo+PyF101 M-MuLV enhancer variant: implications for sites of generation and roles in leukemogenesis. J Virol 73:5671-80

Showing the most recent 10 out of 46 publications